Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Double-Blind Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil

NCT00672945 is registered in ClinicalTrials.gov with Epix Pharmaceuticals, Inc. as lead sponsor.

NCT NCT00672945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00672945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Double-Blind Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil
Lead sponsor
Epix Pharmaceuticals, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
April 30, 2008
Completion date
Not reported
Enrollment
420 (estimated)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease